Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Funding callMedicine and clinical research · International

ERDERA Joint Transnational Call 2027 – Recently identified rare diseases

The ERDERA Joint Transnational Call 2027, from the European Rare Diseases Research Alliance, supports transnational consortia doing collaborative research on recently identified rare diseases. This guide covers research areas consistent with the call, eligibility and readiness checks, what panels typically value and how to prepare for the 1 February 2027 date listed here, with the call expected to open on 1 December 2026 and second-stage applications due on 24 June 2027, all dates provisional.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
1 February 2027
Last checked
10 November 2026
Funder
European Rare Diseases Research Alliance (ERDERA)
Sources
1
Apply through the official call

Key dates

Application deadline
1 February 2027
Details last checked
10 November 2026
Apply through the official call

About the call

Funder
European Rare Diseases Research Alliance (ERDERA)
Country
International
Scheme type
Project grant
Funding
As stated in the call documents
Eligibility
Transnational consortia doing collaborative research on newly discovered rare diseases; expected to open 1 Dec 2026 with second-stage applications due 24 Jun 2027 (dates provisional).
Scope
Medicine and clinical research

Topics consistent with the call

  • Clinical and molecular characterisation of newly discovered rare diseases
  • Natural history studies and patient registries for recently identified conditions
  • Disease mechanism studies using cellular and animal models
  • Development of diagnostic approaches for newly described rare diseases
  • Identification of therapeutic targets and early-stage treatment strategies

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you apply

  1. Confirm that the target disease qualifies as recently identified under the call definitions.
  2. Form a transnational consortium that meets the call’s composition rules.
  3. Check each partner’s eligibility under the relevant national or regional funding rules.
  4. Confirm the provisional call dates and the two-stage process in the official call documents.
  5. Prepare a complete, institutionally approved application before the deadline.

Why This Funding Call Matters

Advances in genomic sequencing have led to the discovery of many new rare diseases, but knowledge of their clinical course, mechanisms and management often remains limited. Because patients with each condition are few and widely dispersed, research depends on collaboration across countries. A joint transnational call focused on recently identified rare diseases helps consortia pool patients, data and expertise, and supports the early research needed to improve diagnosis and lay foundations for future therapies.

Who Should Apply

Academic backgrounds

  • Medical genetics
  • Paediatrics and neurology
  • Molecular and cell biology
  • Bioinformatics
  • Clinical research

Institutions and sectors

  • Universities and academic hospitals
  • Public research organisations
  • Rare disease reference centres
  • Small and medium-sized enterprises where eligible

What Reviewers Typically Value

  1. A clearly justified focus on diseases that are recently identified and poorly characterised.
  2. Genuine transnational added value, with complementary expertise across partners.
  3. Feasible plans to recruit patients or access samples across countries.
  4. Outcomes that improve diagnosis, understanding or future treatment options.

Ideas You Could Develop

Phenotyping a newly described syndromeA consortium project collecting standardised clinical and genetic data to define the phenotype spectrum of a recently identified neurodevelopmental disorder.
Patient-derived models of diseaseA project using patient-derived induced pluripotent stem cells to study the cellular mechanisms of a newly discovered metabolic disease.
Diagnostic pathway for novel variantsA collaborative study developing and testing a functional assay to classify variants in a recently implicated disease gene.

Your Plan to the Deadline

A suggested schedule working back from 1 February 2027. Adjust it to the stage your work has reached.

  1. By 7 Dec 2026

    Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.

  2. By 21 Dec 2026

    Agree the research question, aims, team and partners; contact your research office.

  3. By 4 Jan 2027

    Draft the case for support, methods, impact and budget.

  4. By 18 Jan 2027

    Obtain internal review, letters of support and institutional sign-off.

  5. By 27 Jan 2027

    Final checks against the funder’s guidance and formatting rules.

  6. By 1 Feb 2027

    Submit through the funder’s system before the deadline.

What you gain

  • Funding for the research, team and resources it needs.
  • Recognition from a competitive, peer-reviewed process.
  • Reviewer feedback that strengthens future applications.
  • A track record for larger grants and fellowships.

What happens after you apply

  1. Eligibility check: the funder confirms the application meets the call rules.
  2. Peer review: external reviewers assess the proposal against the published criteria.
  3. Panel: a committee ranks proposals; some schemes include an interview.
  4. Decision: outcomes are released on the funder’s timetable.
  5. Award: successful applicants agree terms and reporting requirements before starting.

What the Funder Are Looking For

ERDERA is looking for transnational consortia undertaking collaborative research on recently identified rare diseases. Strong proposals typically show scientific excellence, clear added value from working across countries, a feasible plan for accessing patients or samples and outcomes that benefit patients. Because call dates are provisional, eligibility, consortium rules, national funding conditions and timelines should be confirmed in the official ERDERA call documents.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

Expert help

How Pubrica Can Help

Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.

Grant writingProposal writing structured to the funder’s guidance and assessment criteria. Literature review and gap analysisThe evidence base and the gap your proposal addresses. Study designStudy design and methods that reviewers can assess. Statistical analysis planSample size and analysis plans for the proposal. Data management planData management and sharing plans to funder requirements. Proposal editingEditing of the full proposal for clarity and consistency.
Go to the official page

FAQs

Questions Researchers Ask

The next published deadline is 1 February 2027. Dates can change, so confirm them on the official page before you plan your work.

The call focuses on newly discovered rare diseases, but the precise definition, such as a time limit since first description, is set out in the call documents. Applicants should check the official ERDERA call text and contact their national funding contact point if uncertain.

Transnational consortia doing collaborative research on newly discovered rare diseases; expected to open 1 Dec 2026 with second-stage applications due 24 Jun 2027 (dates provisional). Confirm the full eligibility rules in the call documents.

Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.

Sources

  1. European Rare Diseases Research Alliance (ERDERA). (2026). ERDERA Joint Transnational Call 2027 – Recently identified rare diseases. Retrieved 10 November 2026, from https://anr.fr/en/call-for-proposals-details/call/preannouncement-erdera-2027-catalysing-collaborative-research-for-recently-identified-rare-diseases/

How to cite this page

Pubrica Insights. (2026). ERDERA Joint Transnational Call 2027 – Recently identified rare diseases. Pubrica. https://pubrica.com/insights/calls-and-conferences/erdera-joint-transnational-call-2027-recently-identified-rare-diseases/

  • Rare diseases
  • ERDERA
  • Transnational research
  • Genetics
  • Europe

Other Open Funding Calls

Closes 19 November 2026FAPESP Young Investigator Grant for International ResearchersBrazil Closes 24 November 2026MSCA Doctoral Networks 2026 (HORIZON-MSCA-2026-DN-01)International Closes 30 November 2026First in the World Challenge Grants 2026India

All calls, conferences and fundingGrant writing

ERDERA Joint Transnational Call 2027 – Recently identified rare diseasesNext deadline 1 February 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.